Clinical Trials Browser

Phase EARLY_PHASE1 × nilotinib × Clear all

NCT03228303 2017-10-10

Nilotinib Versus Imatinib in Treatment of Patients With Newly Diagnosed Chronic Myeloid Leukemia

Phase EARLY_PHASE1 Unknown

MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT02774512 2017-10-06

ZAK-0

Phase EARLY_PHASE1 Withdrawn

Gastrointestinal

Colonic Neoplasms

NCT01275586 2017-04-12

Study of Tasigna®/Nilotinib (AMN107) in Neurofibromatosis (NF1) Patients With Plexiform Neurofibromas

Phase EARLY_PHASE1 Completed

6 enrolled 7 charts

Neurofibroma, Neurofibromatoses, Neurofibroma, Plexiform